Yoshiaki Ito

11PUBLICATIONS
61CO-AUTHORS
Haematological tumoursBiomedical imagingCancer cell biologyMolecular targetsEvolution of developmental systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 20, 2025
An Upstream RUNX3 Enhancer, eR3 (-18m/-28h), Regulates the Development of Gut-Associated Anti-Tumorigenic CD8+CD103+ Cytotoxic T Lymphocytes in Mouse and Human.

Giselle Sek Suan Nah, Junichi Matsuo, Avinash Govind Bahirvani

|Aug 19, 2025
Wnt target IQGAP3 promotes Wnt signaling via disrupting Axin1-CK1α interaction.

Muhammad Bakhait Rahmat, Aashiq Hussain, Yu Xuan Teh

|Oct 22, 2024
IQGAP3 signalling mediates intratumoral functional heterogeneity to enhance malignant growth.

Mitsuhiro Shimura, Junichi Matsuo, ShuChin Pang

|Jan 19, 2024
Aberrant Upregulation of RUNX3 Activates Developmental Genes to Drive Metastasis in Gastric Cancer.

Kazuto Suda, Atsushi Okabe, Junichi Matsuo

|Jul 03, 2023
RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade.

Vincent Oei, Linda Shyue Huey Chuang, Junichi Matsuo

|Feb 11, 2023
RUNX3 in Stem Cell and Cancer Biology.

Linda Shyue Huey Chuang, Junichi Matsuo, Daisuke Douchi

Pageof 2